{"id":327,"date":"2025-08-07T11:30:27","date_gmt":"2025-08-07T11:30:27","guid":{"rendered":"https:\/\/www.libertymanagement.us\/fda-support\/?p=327"},"modified":"2025-08-07T16:31:26","modified_gmt":"2025-08-07T16:31:26","slug":"mocra","status":"publish","type":"post","link":"https:\/\/www.libertymanagement.us\/fda-support\/2025\/08\/07\/mocra\/","title":{"rendered":"MoCRA"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">MoCRA stands for the Modernization of Cosmetics Regulation\nAct of 2022. It expands the FDA&#8217;s authority over cosmetics, introduces\nmandatory registration, safety, and reporting requirements, and aims to\nstrengthen public health protections for cosmetic products.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Key aspects of MoCRA include:<\/p>\n\n\n\n<ul class=\"wp-block-list\"><li><a href=\"https:\/\/www.fdahelp.us\/fda-mocra-registration-listing-cosmetic-facility.html\">Facility\nRegistration<\/a>: Cosmetic manufacturers and processors must register their\nfacilities with the FDA and update such registration biennially.<\/li><li><a href=\"https:\/\/www.fdahelp.us\/fda-cosmetic-registration.html\">Product Listing:<\/a>\nA responsible person must list every marketed product (including ingredients)\nand renew such listing annually.<\/li><li>Good Manufacturing Practices (GMP): The law\nrequires compliance to GMPs, which sets standards for product safety and\nquality in manufacturing.<\/li><li>Adverse event reporting: Manufacturers must\ntrack and report any serious adverse health incidents linked to their products.<\/li><li>Safety substantiation: Companies must do all safety\ntesting and keep evidence.<\/li><li><a href=\"https:\/\/www.fdahelp.us\/cosmetics-labeling.html\">Labeling requirements<\/a>:\nProduct labels must be FDA compliant.<\/li><\/ul>\n\n\n\n<p class=\"wp-block-paragraph\">Certain Small businesses may be exempt from some MoCRA requirements, although exemptions do not apply to products intended for use in the eyes, injected, or otherwise specifically regulated under FDA drug regulation.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Liberty Management Group Ltd can help facilities with FDA\nRegistration &amp; product listing and label compliance.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Namrata <\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Regulatory Consultant<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"mailto:support@libertymanagement.us\">support@libertymanagement.us<\/a><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><a href=\"http:\/\/www.fdahelp.us\">http:\/\/www.fdahelp.us<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>MoCRA stands for the Modernization of Cosmetics Regulation Act of 2022. It expands the FDA&#8217;s authority over cosmetics, introduces mandatory registration, safety, and reporting requirements, and aims to strengthen public health protections for cosmetic products. Key aspects of MoCRA include: Facility Registration: Cosmetic manufacturers and processors must register their facilities with the FDA and update &hellip; <a href=\"https:\/\/www.libertymanagement.us\/fda-support\/2025\/08\/07\/mocra\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;MoCRA&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,1,38],"tags":[70],"class_list":["post-327","post","type-post","status-publish","format-standard","hentry","category-cosmetics-regulations","category-uncategorized","category-us-fda-registration","tag-mocra"],"_links":{"self":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/327","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/comments?post=327"}],"version-history":[{"count":2,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/327\/revisions"}],"predecessor-version":[{"id":329,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/posts\/327\/revisions\/329"}],"wp:attachment":[{"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/media?parent=327"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/categories?post=327"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.libertymanagement.us\/fda-support\/wp-json\/wp\/v2\/tags?post=327"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}